Entering text into the input field will update the search result below

Menlo expands insurance coverage of acne foam Amzeeq

May 27, 2020 10:45 AM ETVYNE Therapeutics Inc. (VYNE) StockVYNEBy: Douglas W. House, SA News Editor
  • Menlo Therapeutics (MNLO -4.2%) announces that "one of the largest" U.S. insurers has added Amzeeq (minocycline) topical foam, 4% to its formulary for the treatment of acne vulgaris in patients as young as nine years old.
  • CEO David Domzalski says, “We are pleased with the continued expansion of our national coverage for Amzeeq. With this additional plan under contract, we now have coverage for up to 60% of the total commercial lives in the United States.”

Recommended For You

More Trending News

About VYNE Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
VYNE--
VYNE Therapeutics Inc.